Literature DB >> 22683674

Blocking vertical transmission of human T cell lymphotropic virus type 1 and 2 through breastfeeding interruption.

Maísa A Ribeiro1, Marina L Martins, Carolina Teixeira, Roberto Ladeira, Maria de Fátima Oliveira, José Nélio Januário, Fernando A Proietti, Anna Bárbara de Freitas Carneiro-Proietti.   

Abstract

BACKGROUND: Human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) causes serious diseases and is endemic in many parts of the world. It is transmitted from mother to child in 15-25% of the cases, primarily through breastfeeding. Proviral load and duration of breastfeeding are thought to play a role in transmission. This study aimed to detect HTLV-seropositive mothers through testing of neonates, to evaluate maternal HTLV proviral load and to measure the rates of transmission blocking when interruption of breastfeeding was implemented.
METHODS: Neonates were screened for HTLV-1/2 IgG by enzyme immunoassay using the neonatal screening program of Minas Gerais State, Brazil. Breastfeeding interruption was recommended to those whose mothers were confirmed HTLV-positive. Children were tested by polymerase chain reaction at birth and at 12 months of age.
RESULTS: Of 55,293 neonates tested, 42 (0.076%) were positive for HTLV-1 or HTLV-2 IgG. All 42 were polymerase chain reaction-negative at birth and 1 of 37 (2.7%) became antibody-positive after 12 months. His mother had delivered him vaginally and was informed of the positive HTLV-1 polymerase chain reaction after 7 days of breastfeeding. The mother's proviral load was 271 copies/10,000 cells, whereas the average is 109.2 copies/10,000 cells (95% confidence interval: 70.56-147.83).
CONCLUSIONS: Maternal HTLV-1 proviral load and the route of delivery may have played a role in the transmission observed. Avoidance of breastfeeding was an effective measure to reduce HTLV transmission. In endemic countries, routine prenatal or neonatal screening combined with formula feeding for mothers confirmed HTLV-positive may be an important strategy to prevent future development of illnesses related to HTLV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683674     DOI: 10.1097/INF.0b013e318263215e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 2.  Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.

Authors:  DeGaulle I Chigbu; Pooja Jain; Brenndan L Crumley; Dip Patel; Zafar K Khan
Journal:  J Neurovirol       Date:  2019-01-28       Impact factor: 3.739

3.  Pregnancy outcomes and mother-to-child transmission rate in HTLV-1/2 infected women attending two public hospitals in the metropolitan area of Rio de Janeiro.

Authors:  Danielle Bittencourt Sodré Barmpas; Denise Leite Maia Monteiro; Stella Regina Taquette; Nádia Cristina Pinheiro Rodrigues; Alexandre José Baptista Trajano; Juliana de Castro Cunha; Camila Lattanzi Nunes; Lucia Helena Cavalheiro Villela; Sérgio A M Teixeira; Denise Cardoso das Neves Sztajnbok; Márcio Neves Bóia
Journal:  PLoS Negl Trop Dis       Date:  2019-06-10

Review 4.  A Nationwide Antenatal Human T-Cell Leukemia Virus Type-1 Antibody Screening in Japan.

Authors:  Kazuo Itabashi; Tokuo Miyazawa; Akihiko Sekizawa; Akifumi Tokita; Shigeru Saito; Hiroyuki Moriuchi; Yasuhito Nerome; Kaoru Uchimaru; Toshiki Watanabe
Journal:  Front Microbiol       Date:  2020-04-09       Impact factor: 5.640

5.  Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands.

Authors:  Maria Gisele Gonçalves; Lucila Okuyama Fukasawa; Karoline Rodrigues Campos; Fábio Takenori Higa; Adele Caterino-de-Araujo
Journal:  Front Microbiol       Date:  2022-03-15       Impact factor: 5.640

6.  HTLV-1 in pregnant women from the Southern Bahia, Brazil: a neglected condition despite the high prevalence.

Authors:  Marco Antônio Gomes Mello; Aline Ferreira da Conceição; Sandra Mara Bispo Sousa; Luiz Carlos Alcântara; Lauro Juliano Marin; Mônica Regina da Silva Raiol; Ney Boa-Sorte; Lucas Pereira Souza Santos; Maria da Conceição Chagas de Almeida; Tâmara Coutinho Galvão; Raquel Gois Bastos; Noilson Lázaro; Bernardo Galvão-Castro; Sandra Rocha Gadelha
Journal:  Virol J       Date:  2014-02-13       Impact factor: 4.099

7.  Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Authors:  Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain
Journal:  BMC Public Health       Date:  2016-08-15       Impact factor: 3.295

Review 8.  Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission.

Authors:  Florent Percher; Patricia Jeannin; Sandra Martin-Latil; Antoine Gessain; Philippe V Afonso; Aurore Vidy-Roche; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2016-02-03       Impact factor: 5.048

9.  Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring.

Authors:  Arthur M Paiva; Tatiane Assone; Michel E J Haziot; Jerusa Smid; Luiz Augusto M Fonseca; Olinda do Carmo Luiz; Augusto Cesar Penalva de Oliveira; Jorge Casseb
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.